Semaglutide Brand Names: Ozempic, Wegovy, and Rybelsus Explained

Semaglutide is sold in the United States under three brand names: Ozempic, Wegovy, and Rybelsus. Ozempic and Wegovy are once-weekly injections, while Rybelsus is a once-daily oral tablet. All three are made by Novo Nordisk, and semaglutide is the generic, nonproprietary name of the active ingredient they share.

What Is the Generic Name for Semaglutide?

The semaglutide generic name is simply "semaglutide." Every medicine has one nonproprietary name that stays the same no matter how many companies sell it or how many brand names exist.

Brand names, on the other hand, are trademarks owned by a manufacturer. That is why the answer to "what is the brand name for semaglutide" depends entirely on which version is being prescribed.

• Ozempic — injectable semaglutide approved for type 2 diabetes and cardiovascular risk reduction.
• Wegovy — injectable semaglutide approved for chronic weight management, cardiovascular risk reduction, and noncirrhotic MASH.
• Rybelsus — oral semaglutide approved for type 2 diabetes.

There is no FDA-approved generic semaglutide on the US market. Novo Nordisk holds semaglutide patents that run into the early 2030s in the United States, so a true generic version is not expected soon.

Brand name	Generic name	Form	Main FDA-approved use	Manufacturer
Ozempic	Semaglutide	Once-weekly injection	Type 2 diabetes; cardiovascular risk reduction	Novo Nordisk
Wegovy	Semaglutide	Once-weekly injection	Chronic weight management; cardiovascular risk reduction; MASH	Novo Nordisk
Rybelsus	Semaglutide	Once-daily oral tablet	Type 2 diabetes	Novo Nordisk

Ozempic vs. Wegovy vs. Rybelsus: How the Brands Differ

All three products contain the same active molecule, but they are not interchangeable. The FDA approves each semaglutide brand for specific doses, populations, and conditions.

Brand	Starting dose	Maximum dose	Typical schedule
Ozempic	0.25 mg	2 mg	Once weekly injection
Wegovy	0.25 mg	2.4 mg	Once weekly injection
Rybelsus	3 mg	14 mg	Once daily by mouth

Ozempic is titrated upward to 1 mg or 2 mg for blood sugar control. Wegovy follows a similar escalation but reaches 2.4 mg for weight management. Rybelsus comes in 3 mg, 7 mg, and 14 mg tablets and must be taken on an empty stomach with a small amount of water.

Insurance coverage usually follows the FDA-approved indication. Ozempic is most often covered for diabetes, while Wegovy is the brand most often covered for obesity.

Compounded Semaglutide and the "Semaglutide Pyridoxine" Label

During the semaglutide shortage, some compounding pharmacies sold their own semaglutide, often combined with vitamin B6 (pyridoxine) in an attempt to reduce nausea. That is why "semaglutide pyridoxine brand name" appears in search results even though no brand-name product combines those two ingredients.

Compounded semaglutide is not FDA-approved. The FDA has warned about dosing errors, unapproved ingredients, and inaccurate labeling in some compounded products, and it removed semaglutide from the drug shortage list in 2025, which sharply limited legal compounding.

Some compounded formulas add other ingredients as well, such as semaglutide l carnitine, which has no established role in semaglutide therapy. If a seller markets a compounded product as a "brand-name" semaglutide, that claim is inaccurate.

Semaglutide Brand Names Outside the United States

Novo Nordisk uses the names Ozempic, Wegovy, and Rybelsus in most major markets, although approved uses and available doses vary by regulator. In the European Union, for example, Wegovy is authorized for weight management and Rybelsus is authorized for type 2 diabetes.

Patents on semaglutide are set to expire in some countries starting in 2026, which could eventually introduce locally manufactured semaglutide brands elsewhere. As of now, every FDA-approved semaglutide product in the US carries a Novo Nordisk brand name.

Investigational Names: CagriSema and Other Combinations

Novo Nordisk is also studying a combination of cagrilintide and semaglutide, an investigational product known as CagriSema. It has not been approved by the FDA for any use, and there is currently no approved cagrilintide brand in the United States.

People researching weight-loss drugs frequently compare retatrutide vs tirzepatide vs semaglutide, but only semaglutide and tirzepatide are approved for human use today. For reference, the brand names of tirzepatide are Mounjaro and Zepbound.

Safety, Side Effects, and Legal Status

Every semaglutide product is prescription-only in the United States and should be used under medical supervision. These drugs carry a boxed warning about thyroid C-cell tumors seen in rodents and are not recommended for people with a personal or family history of medullary thyroid cancer or MEN2.

• Common side effects: nausea, vomiting, diarrhea, constipation, and abdominal pain.
• Serious risks: pancreatitis, gallbladder disease, kidney injury, and worsening diabetic retinopathy.
• Age limits: Wegovy is approved for ages 12 and older; Ozempic and Rybelsus are approved for adults.

Anyone considering semaglutide should talk with a licensed healthcare professional first, especially if they take insulin, sulfonylureas, or other medications that lower blood sugar. Buying semaglutide from unverified online sellers raises the risk of receiving a counterfeit, mislabeled, or contaminated product.

The Bottom Line on Semaglutide Names

Semaglutide brand names in the US are Ozempic, Wegovy, and Rybelsus, and all three contain the same active ingredient. The brand determines the approved use, the dose, and the dosage form, not the drug itself. Anyone unsure which version is right for them should ask a pharmacist or physician rather than relying on a brand name alone.

COMMON QUESTIONS

Frequently Asked Questions

Is there a generic semaglutide available in the US?

No. There is no FDA-approved generic semaglutide sold in the United States. Novo Nordisk's patents on semaglutide run into the early 2030s in the US, so a true generic version is not expected soon. Compounded semaglutide sold during the shortage was not FDA-approved and is not the same as a generic.

What is the difference between Ozempic and Wegovy if they contain the same drug?

Ozempic and Wegovy both contain semaglutide, but they are approved for different uses and maximum doses. Ozempic is approved for type 2 diabetes with a maximum dose of 2 mg weekly. Wegovy is approved for chronic weight management and reaches 2.4 mg weekly. Insurance coverage usually follows the approved indication.

Is Rybelsus the same medication as Ozempic?

Rybelsus and Ozempic both contain semaglutide, but Rybelsus is a once-daily oral tablet while Ozempic is a once-weekly injection. Rybelsus is approved for type 2 diabetes, and it must be taken on an empty stomach with a small amount of water. A prescriber decides which form is appropriate based on the patient's needs.